Compare MRNA & DAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
Dayforce is a global technology company providing cloud-based human capital management solutions for large businesses looking to manage their payroll, tax, benefits, and talent intelligence. The company primarily services customers in the US with its flagship Dayforce platform but also services customers in select European countries as well as Australia and New Zealand. Dayforce services the Canadian HCM market with its Powerpay platform that specifically targets customers with less than 100 employees. As of fiscal 2024, the Dayforce platform accounted for almost 80% of companywide revenue and had 6,876 clients representing approximately 7.62 million employees.